Hemispherx Biopharma Release: Japan Institute of Infectious Diseases Publishes Second Article On Ampligen as Avian Flu Vaccine Immune Enhancer

PHILADELPHIA, Nov. 12, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that its collaborative partner, Japan’s National Institute of Infectious Diseases (JNIID), has published an article in the Institut Pasteur’s publication Microbes and Infection 9 (2007) 1333-1340.